News Pulsenmore Ltd.

Stocks

PLSM

IL0011767006

Advanced Medical Equipment & Technology

End-of-day quote TEL AVIV STOCK EXCHANGE 2026-08-12			5-day change	1st Jan Change
883.00 ^ILa	-10.45%		-17.09%	-57.73%

07-13	Pulsenmore Selected For Israel Innovation Authority And Ministry Of Health Program To Lead $1 Million AI Development Project	CI
07-02	Pulsenmore Files Resale Registration for 3.1 Million Shares	MT

All News

Mentions Relevance

07-13	Pulsenmore Selected For Israel Innovation Authority And Ministry Of Health Program To Lead $1 Million AI Development Project	CI
07-02	Pulsenmore Files Resale Registration for 3.1 Million Shares	MT
06-26	Pulsenmore Ltd. announced that it has received $7.499844 million in funding	CI
06-25	Pulsenmore to Raise $7.5 Million in Equity Private Placement	MT
06-24	Pulsenmore Ltd. announced that it expects to receive $7.499844 million in funding	CI
06-24	Top Midday Gainers	MT
06-24	Pulsenmore Enters Partnership with Ouma Health for its Home Ultrasound Platform; Shares Rise Pre-Bell	MT
06-24	Pulsenmore Ltd. And Ouma Health Enter Strategic Partnership To Expand Access To Remote Prenatal Care Across The United States	CI
03-30	Pulsenmore : Corporate Presentation (Pulsenmore Investor Deck 03302026 )	PU
03-30	Pulsenmore Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-18	Pulsenmore : Announces Full Year 2025 Earnings Conference Call	PU
02-09	Pulsenmore Ltd. Enters Commercial Engagement With TLC Perinatal For Home Ultrasound Services In U.S	CI
02-02	Pulsenmore Ltd. Announces First Commercial Engagement with a Leading U.S. Based Medical Center	CI
01-26	Pulsenmore Ltd. and Clalit Health Services Launch First At-Home Follicular Monitoring Service for IVF and Fertility Preservation	CI
01-21	Pulsenmore Ltd.(NasdaqCM:PLSM) added to NASDAQ Composite Index	CI
01-20	Pulsenmore Ltd. will Change its Ticker to PLSM from PULS	CI
11-03	Pulsenmore Ltd. Receives FDA De Novo Marketing Authorization for Home-Use Prenatal Ultrasound, Pioneering a New Era of Prenatal Care in the U.S	CI
11-03	Pulsenmore Receives FDA De Novo Marketing Authorization for Home-Use Prenatal Ultrasound, Pioneering a New Era of Prenatal Care in the U.S.	PR
25-08-30	Pulsenmore Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-03-30	Pulsenmore Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24-10-29	Pulsenmore Ltd. Expands Partnership with Clalit Health Services to Deliver 25,000 Home Ultrasound Devices for Remote Prenatal Care	CI
24-08-15	Pulsenmore Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-06-03	Pulsenmore Ltd. Appoints Len Farris as Chief Commercial Officer	CI
24-03-28	Pulsenmore Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-03-13	Pulsenmore Ltd. Expanding the Application of Its Home Ultrasound Solution for Pregnant Women	CI